Dorling Janet 4
4 · CymaBay Therapeutics, Inc. · Filed Apr 5, 2021
Insider Transaction Report
Form 4
Dorling Janet
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-05+80,000→ 80,000 totalExercise: $4.63Exp: 2031-04-04→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/36 of the underlying shares monthly from April 5, 2021.